drugset / Trial / NCT04454840
Treatment of Intravenous Infusion Plasma in Amyotrophic Lateral Sclerosis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and effectiveness of intravenous infusion of plasma from healthy young people for the treatment of amyotrophic lateral sclerosis.
Timeline
- Start
- 2016-05-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plasma from healthy young people | Unknown | 400 ml | Intravenous |
| Comparator | Riluzole | Small molecule | 25 mg | — |
| Comparator | Riluzole | Small molecule | 50 mg | — |